| Mar 6 2020 |
Managing the Commercial Impact of the Coronavirus: Food & Beverage |
Foley & Lardner LLP |
| Mar 6 2020 |
EPA Releases List of Disinfectants for Use against COVID-19 |
Bergeson & Campbell, P.C. |
| Mar 5 2020 |
Clinical Trial Results Will See Daylight After HHS Final Rule Is Set Aside |
Mintz |
| Mar 5 2020 |
Nota Bene Episode 71: Shifting Regulatory Landscapes at the FDA: Cannabis, Vaping and Intelligent Medical Devices with Allison Fulton [PODCAST] |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 5 2020 |
Antitrust Liability Risk When Listing Patents in Orange Book |
McDermott Will & Schulte LLP |
| Mar 5 2020 |
How FDA is Reacting to the Coronavirus, and 2020 Regulatory Priorities |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 5 2020 |
Dairy Industry Urges FDA to Prohibit the Use of Traditional Dairy Terms on Plant-Based Products |
Keller and Heckman LLP |
| Mar 5 2020 |
Comments on Proposed Supplemental SNUR on LCPFAC Chemical Substances Due April 17 |
Bergeson & Campbell, P.C. |
| Mar 5 2020 |
NIOSH CIB on Practices in Occupational Risk Assessment Addresses Nanomaterials |
Bergeson & Campbell, P.C. |
| Mar 4 2020 |
FDA’s Evolving Response to the COVID-19 (Coronavirus) Outbreak |
Mintz |
| Mar 4 2020 |
Federal Preemption in the Wake of Albrecht: The U.S. Supreme Court Unexpectedly Levels the Playing Field |
Sills Cummis & Gross P.C. |
| Mar 4 2020 |
What COVID-19 Means for FDA-Regulated Industry |
Polsinelli PC |
| Mar 4 2020 |
In Enforcement Action, SEC Underscores Heightened Scrutiny of KPIs in MD&A Reporting |
Faegre Drinker |
| Mar 4 2020 |
The 2019 Honig Act Means New Obligations for New Jersey Employers Around Cannabis at Work |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Mar 4 2020 |
Proposed Class Action Urges Court Not to Dismiss Suit Against Florida CBD Manufacturer |
Keller and Heckman LLP |
| Mar 3 2020 |
FDA Finalizes Clinical Laboratory Guidance Documents For In Vitro Diagnostic Tests |
Barnes & Thornburg LLP |
| Mar 3 2020 |
PFAS Update: EPA Begins Process of Developing Drinking Water Limits for PFOS and PFOA |
Greenberg Traurig, LLP |
| Mar 3 2020 |
EFSA Publishes Draft Scientific Opinion on PFASs in Food |
Keller and Heckman LLP |
| Mar 3 2020 |
Disposables are Making Vaping Harder to Detect Among Teens |
Stark & Stark |
| Mar 3 2020 |
EPA Extends Comment Period for Proposed Registration Decision for New Nanosilver Product |
Bergeson & Campbell, P.C. |
| Mar 2 2020 |
FDA Launches Limited Pilot Program For Interactive 510(K) Application |
Barnes & Thornburg LLP |
| Mar 2 2020 |
FIFRA Stakeholders: How to Respond to an Enforcement Action or Inquiry |
Bergeson & Campbell, P.C. |
| Mar 2 2020 |
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums |
Foley & Lardner LLP |
| Mar 2 2020 |
Germany Publishes English Translation of TRGS 527: Activities with Nanomaterials |
Bergeson & Campbell, P.C. |
| Mar 2 2020 |
Florida Medical Marijuana Users May Soon Become Protected Class Under State Employment Laws |
Foley & Lardner LLP |
| Mar 2 2020 |
FDA Extends Comment Period on Proposed Rule for Laboratory Accreditation Program |
Keller and Heckman LLP |
| Feb 28 2020 |
340B In The Spotlight – CMS 340B Acquisition Cost Survey Proposal & President’s Budget |
Polsinelli PC |
| Feb 28 2020 |
DEA Initiates Rule making to Waive Separate Registration for Mobile NTP |
McDermott Will & Schulte LLP |
| Feb 28 2020 |
Biobased Plastics and the Sustainability Puzzle* |
Keller and Heckman LLP |
| Feb 28 2020 |
ASTM International Biotechnology Task Group Seeking Members |
Bergeson & Campbell, P.C. |
| Feb 28 2020 |
FSANZ Releases 2019 Food Recall Statistics |
Keller and Heckman LLP |
| Feb 28 2020 |
FDA Upgrades Its Database Of Licensed Biological Products & Amends It's Definition |
Bergeson & Campbell, P.C. |
| Feb 28 2020 |
Federal Circuit Changes the Game for Selling Single-API Drugs to the Government |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 28 2020 |
Proposed Supplemental SNUR Would Remove Exemption for LCPFAC Chemical Substances Used as Surface Coatings on Articles |
Bergeson & Campbell, P.C. |
| Feb 28 2020 |
False Claims Act Whistleblower Recovers More than $2.5M in Damages in False Claims Act Whistleblower Retaliation Case |
Zuckerman Law |
